Artículos por temáticas

Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology

Obulesu M, Jhansilakshmi M.

Int J Neurosci. 2014 Apr;124(4):227-35. doi: 10.3109/00207454.2013.831852. Epub 2013 Sep 12.

Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele

Qiu WW, Lai A, Mon T, Mwamburi M, Taylor W, Rosenzweig J, Kowall N, Stern R, Zhu H, Steffens DC.

Am J Geriatr Psychiatry. 2014 Feb;22(2):177-85. doi: 10.1016/j.jagp.2012.08.017. Epub 2013 Apr 3.

The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's disease

Kljajevic V, Meyer P, Holzmann C, Dyrba M, Kasper E, Bokde AL, Fellgiebel A, Meindl T, Hampel H, Teipel S; EDSD study group.

Alzheimers Dement. 2014 May;10(3):401-4. doi: 10.1016/j.jalz.2013.02.008. Epub 2013 May 21.

The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease

Wan W, Chen H, Li Y.

Int J Neurosci. 2014 Feb;124(2):75-81. doi: 10.3109/00207454.2013.825258. Epub 2013 Aug 15.

In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approaches

Balducci C, Forloni G.

Curr Pharm Des. 2014;20(15):2491-505. doi: 10.2174/13816128113199990497.

Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations

Reitz C, Mayeux R.

Biol Psychiatry. 2014 Apr 1;75(7):534-41. doi: 10.1016/j.biopsych.2013.06.003. Epub 2013 Jul 25.

Amyloid and its association with default network integrity in Alzheimer's disease

Adriaanse SM, Sanz-Arigita EJ, Binnewijzend MA, Ossenkoppele R, Tolboom N, van Assema DM, Wink AM, Boellaard R, Yaqub M, Windhorst AD, van der Flier WM, Scheltens P, Lammertsma AA, Rombouts SA, Barkho

Hum Brain Mapp. 2014 Mar;35(3):779-91. doi: 10.1002/hbm.22213. Epub 2012 Dec 14.

The CLU gene rs11136000 variant is significantly associated with Alzheimer's disease in Caucasian and Asian populations

Liu G, Wang H, Liu J, Li J, Li H, Ma G, Jiang Y, Chen Z, Zhao B, Li K.

Neuromolecular Med. 2014 Mar;16(1):52-60. doi: 10.1007/s12017-013-8250-1. Epub 2013 Jul 28.

A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations

Roussotte FF, Jahanshad N, Hibar DP, Sowell ER, Kohannim O, Barysheva M, Hansell NK, McMahon KL, de Zubicaray GI, Montgomery GW, Martin NG, Wright MJ, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; ADNI

Hum Brain Mapp. 2014 Apr;35(4):1226-36. doi: 10.1002/hbm.22247. Epub 2013 Feb 21.

Callosal degeneration topographically correlated with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease dementia

Wang PN, Chou KH, Chang NJ, Lin KN, Chen WT, Lan GY, Lin CP, Lirng JF.

Hum Brain Mapp. 2014 Apr;35(4):1529-43. doi: 10.1002/hbm.22271. Epub 2013 May 14.

Alzheimer's disease: new data highlight nonneuronal cell types and the necessity for presymptomatic prevention strategies

Gandy S.

Biol Psychiatry. 2014 Apr 1;75(7):553-7. doi: 10.1016/j.biopsych.2013.11.019. Epub 2013 Nov 28.

Autophagy dysfunction and its link to Alzheimer's disease and type II diabetes mellitus

Wilson CM, Magnaudeix A, Yardin C, Terro F.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):226-46. doi: 10.2174/18715273113126660146.

Subcellular injuries in Alzheimer's disease

Tillement JP, Papadopoulos V.

CNS Neurol Disord Drug Targets. 2014;13(4):593-605. doi: 10.2174/18715273113126660197.

Imaging markers of structural and functional brain changes that precede cognitive symptoms in risk for Alzheimer's disease

Burggren A, Brown J.

Brain Imaging Behav. 2014 Jun;8(2):251-61. doi: 10.1007/s11682-013-9278-4.

Is synaptic loss a unique hallmark of Alzheimer's disease?

Scheff SW, Neltner JH, Nelson PT.

Biochem Pharmacol. 2014 Apr 15;88(4):517-28. doi: 10.1016/j.bcp.2013.12.028. Epub 2014 Jan 9.